Back to search

University of Thessaly (UTH)

Mycobacterium tuberculosis: αντοχή στα αντιφυματικά και διερεύνηση της αντοχής

Abstract

dc:description

Mycobacterium tuberculosis is an immobile, obligate aerobic, acid-fast bacillus and belongs to the high G+C Gram-positive bacteria. It is the causative agent of tuberculosis, which is one of the major public health problems with high morbidity and mortality worldwide. A recent report by the World Health Organization (WHO) estimated 10.0 million new cases and 1.6 million deaths from TB in 2017 from tuberculosis. Its treatment is long and consists of two phases. The initial phase includes rifampicin (RIF), isoniazid (INH), pyrazinamide (PZA), ethambutol (EMB) as first-line anti-tuberculosis agents. Streptomycin (STR) is a second-line drugs, however, it is still incorporated into first-line regimens. In recent years, the increasing prevalence of drugs resistant tuberculosis (DR-TB), especially multidrug-resistant tuberculosis (MDR-TB, resistant to both INH and RIF) and extensively drug-resistant tuberculosis (XDR-TB, resistant to isoniazid and rifampin, plus any fluoroquinolone and at least one of second-line drugs, amikacin or kanamycin or capreomycin) is a major problem. The immediate treatment is extremely important not only for the successful outcome of the patient but also for the reduction of the spread of the M. tuberculosis in the environment. Unfortunately, the generation time of the mycobacterium is long and that is why its isolation and its drug susceptibility testing are time consuming. The molecular techniques play important roles in both the direct detection of the M. tuberculosis in the clinical sample and the detection of the main mutations associated with resistance. The aim of this study was to determine the resistance rate of M. tuberculosis strains, isolated from patients in Thessaly, the characterization of mutations associated with drug resistance and to investigate the polymorphisms for epidemiological studies.M. tuberculosis Complex (MTBC) isolates were isolated from patients in the Microbiological Laboratory of the University General Hospital of Larissa during 2009-2017. Isolation and identification of strains were done by phenotypic methods and molecular methods. Subsequently, drug susceptibility testing for first- and second-line TB drugs was performed using the reference method BACTEC MGIT 960, the microdilution method (Sensititre) and the E-test method. Two molecular genotyping methods were used, MST and MIRU-VNTR. At the same time, mutations in genes associated with drug resistance to tuberculosis were detected and were differentiated from polymorphisms.Out of the 265 MTBC isolates, 37 (13.96%) were resistant to TB drugs, of which 31 were identified as M. tuberculosis/M. canettii and 6 as M. bovis. None of MTBC stains were MDR and XDR. Resistance rates of M. tuberculosis / M. canettii strains were 6% in STR, 5.2% in INH, 1.5% in PZA, 1.1% in EMB and 0.4% in RIF. All M. bovis strains were resistant only to PZA. Additional, 17 susceptible strains of M. tuberculosis / M. canettii were randomly selected for further characterization. Most of the stains were isolated from male patients, Greeks over 60 and foreigners between 20-40 years old. Based on the MIRU-VNTR method, the most prevalent genotype was Haarlem (33.3%), following the genotypes S-type (16.7%), Beijing (12.5%), X-type (4.2%), CAS / Delhi (2.1%), LAM (2, 1%), Tur (2.1%). Thirteen isolates were unclassified (27%). Based on the MST method, the strains classified into known MST groups: ST6 (20.8%), ST13 (14.6%), ST3 (12.5%), ST23 (10.4%), ST26 (8.3%), ST4 (6.3%), ST42 (2.1%), ST77 (2.1%), and into new ST profiles: ST81 (2.1%), ST85 (2.1%), ST86 (2.1 %), ST87 (2.1%), ST88 (4.2%), ST89 (4.2%), ST90 (2.1%), ST91 (2.1%), ST92 (2.1%). There was no correlation between ST profiles and the resistance mutation patterns. The combination of two methods detected that the dominant lineage was the Euro-American. New and known mutations associated with anti-tuberculosis drug resistance identified. Mutations associated with resistance to isoniazid (katG, inhA, mabA genes and in promoter region of inhA and ahpC genes) were detected in 85.7% of isolates. An interesting finding was that a small percentage of INH-resistant strains carried the most common mutations S315T and c-15t, while new or fewer common ones were detected in them. STR-resistant strains carried 81.25% mutations in the rpsL and gidB genes. Phylogenetic polymorphisms of fourteen genes were found during molecular analysis and were associated with specific ST types, MIRU-VNTR families as well as M. bovis strains. This study reveals the complexity of the mechanisms of M. tuberculosis drug resistant strains.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Florou, Zoi
  • Φλώρου, Ζωή

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/48166

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Florou, Zoi; Φλώρου, Ζωή. Mycobacterium tuberculosis: αντοχή στα αντιφυματικά και διερεύνηση της αντοχής. University of Thessaly (UTH), 2020. http://hdl.handle.net/10442/hedi/48166